Dan Turner

4PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersInfant and child healthPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

|May 14, 2026
Multi-omics-based machine learning model predicts response and guides treatment in Crohn's disease: a case study in nutritional therapy-response to editorial.

|Mar 17, 2026
Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg.

Elisabeth De Greef, Dan Turner, Jarosław Kierkuś

|Jan 08, 2026
Efficacy, Safety, and Pharmacokinetics of Golimumab in Children with Moderately-To-Severely Active Ulcerative Colitis: Results from the PURSUIT 2 Study.

Dan Turner, Kathleen G Lomax, Gigi Veereman

Pageof 1

Frequent Collaborators

2 joint publications

Anne M Griffiths

1 joint publications

Kathleen G Lomax

1 joint publications

Ben Kang

1 joint publications

Omoniyi J Adedokun